Scientists from the Indian Institute of Science, Bangalore, study what effect tuberculosis has on the immune system of our body.
You are here
In a novel study, researchers from the Indian Institute of Technology, Bombay, test how oxidative stress induced by a combination of drugs can help fight drug resistant strains of Tuberculosis.
A new study conducted by Pallavi Sinha and group from Institute of Medical Sciences, Banaras Hindu University and Boston Medical Centre has concluded that behavioral factors, like alcohol consumption and smoking, and clinical factors, like previous anti tubercular treatment, increases the risk of multi-drug resistant TB (MDR-TB).
Tuberculosis(TB) has claimed 1.8 million human lives globally according to World Health Organization, in 2015. Despite Bacillus Calmette-Guerin (BCG) vaccine, the only available vaccine for TB, currently one-third of the world is latently infected with TB due to the incompetence of BCG in adults against Mycobacterium tuberculosis, the bacteria responsible for TB.
Scientists from the Central University of Gujarat (CUG), Gandhinagar, use computers to design the most efficient drug against TB. They apply pharmacophore modelling approach to understand the interactions between proteins found in Mycobacterium tuberculosis (Mtb) and the compounds which can suppress the bacteria.
The whole world is struggling with the problem of antibiotic resistance developed by disease causing organisms. The epidemic of Tuberculosis especially plagues countries like India. In their recent research scientists from the Central University, Punjab have identified a new target drug to beat the bacteria’s defense against antibiotics.
A new study at IISc looks to uncover the secret behind the development of drug resistance in TB causing bacteria by testing the efficacy of various commonly available antibiotics. The researchers have found that a combination of commonly available antibiotics along with Augmentin, fights the development of resistance among TB bacteria. This study might throw light on developing new class of drugs that can help contain the spread of deadly tuberculosis, claim the researchers.
A new study by researchers could be a breakthrough in our fight against tuberculosis that has a long history. The researchers have identified an enzyme in the bacteria that causes TB, inhibiting which could kill the bacteria effectively. A first of its kind study, the researchers hope this enzyme can be targeted to develop effective drugs against TB without any side effects.
Though our fight against tuberculosis has a long history, we have not been able to wipe off this bacterial infection from the face of the planet. Even to this day, there are numerous studies all over the world that are trying to find the ‘best’ drug against this killer disease. In a new approach to fight tuberculosis, a recent study has now shone some light on how our body fights Mycobacterium, the causative bacteria of TB. Understanding this mechanism, the researchers say, could open up new vaccines and drugs against TB and help us win the seemingly never ending battle.